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Hypokalaemic periodic paralysis is a rare genetic neuromuscular disease characterized by episodes of skeletal muscle paralysis
associated with low serum potassium. Muscle ﬁbre inexcitability during attacks of paralysis is due to an aberrant depolarizing leak
current through mutant voltage sensing domains of either the sarcolemmal voltage-gated calcium or sodium channel. We report a
child with hypokalaemic periodic paralysis and CNS involvement, including seizures, but without mutations in the known periodic
paralysis genes. We identiﬁed a novel heterozygous de novo missense mutation in the ATP1A2 gene encoding the a2 subunit of the
Na+/K+ -ATPase that is abundantly expressed in skeletal muscle and in brain astrocytes. Pump activity is crucial for Na+ and K+
homeostasis following sustained muscle or neuronal activity and its dysfunction is linked to the CNS disorders hemiplegic migraine
and alternating hemiplegia of childhood, but muscle dysfunction has not been reported. Electrophysiological measurements of
mutant pump activity in Xenopus oocytes revealed lower turnover rates in physiological extracellular K+ and an anomalous
inward leak current in hypokalaemic conditions, predicted to lead to muscle depolarization. Our data provide important evidence
supporting a leak current as the major pathomechanism underlying hypokalaemic periodic paralysis and indicate ATP1A2 as a new
hypokalaemic periodic paralysis gene.
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Hypokalaemic periodic paralysis (hypoPP) is characterized
by episodes of ﬂaccid skeletal muscle paralysis accompa-
nied by low serum potassium that typically occur in the
early morning and last a minimum of hours. The charac-
teristic age of onset is in the early teens. Paralysis occurs
because the muscle membrane undergoes sustained depolar-
ization that renders it inexcitable (Jurkat-Rott et al., 2009).
Mutations in CACNA1S and SCN4A account for 80%
and 10% of hypoPP cases, respectively, while 10% of cases
remain genetically undeﬁned (Matthews et al., 2009). These
genes code for the alpha subunits of voltage-gated calcium
and sodium channels Cav1.1 and Nav1.4, essential for exci-
tation-contraction coupling and sarcolemmal excitability.
HypoPP mutations affect arginine residues in the voltage sen-
sing domains (VSDs) of both channels (Matthews et al.,
2009). These mutations have minor effects on normal channel
activity but introduce a leak current through the VSDs,
known as a ‘gating pore’ current. This anomalous cation cur-
rent (Sokolov et al., 2007; Struyk and Cannon, 2007) is typ-
ically active at resting membrane potential and conducts a net
inward current that depolarizes the muscle, particularly in
hypokalaemic conditions where the hyperpolarizing potas-
sium current through the inward rectiﬁer potassium channel
Kir2.1 is reduced (Suetterlin et al., 2014). Direct loss-of-func-
tion of Kir2.1 channels due to mutations in the KCNJ2 gene
can also lead to periodic paralysis with hypokalaemia in
Andersen-Tawil syndrome (Plaster et al., 2001).
The Na+ /K+ -ATPases convert ATP energy into steep
electrochemical gradients for Na+ and K+ ions across the
plasma membrane (Morth et al., 2007; Clausen et al.,
2017). These gradients are essential for the maintenance
of the resting membrane potential, the generation of elec-
trical impulses and for driving secondary transport. The 2
subunit is expressed in glial cells of the CNS and in cardiac
and skeletal muscle (Orlowski and Lingrel, 1988;
Radzyukevich et al., 2013; Illarionova et al., 2014). To
date, mutations in ATP1A2 have been associated with fa-
milial and sporadic hemiplegic migraine (FHM and SHM)
and alternating hemiplegia of childhood (AHC) (Bassi et
al., 2004; Bøttger et al., 2012; Pelzer et al., 2017), but
skeletal muscle presentations have not been reported.
Here, we describe the clinical features and functional
consequences of a novel ATP1A2 mutation found in a
young male with hypoPP lacking mutations in the known
associated genes (CACNA1S, SCN4A or KCNJ2).
Materials and methods
Genetic analysis
Sanger sequencing of CACNA1S and SCN4A (for common
hypoPP mutations) and the coding region of KCNJ2 was carried
out as previously described (Matthews et al., 2009). Focused
exome sequencing was performed using the Agilent Sure Select
Focused Exome according to the manufacturer’s protocol.
Sanger sequencing was used to analyse the presence of the
ATP1A2 variant in the proband and their parents. All clinical
procedures were undertaken as part of routine clinical care.
Molecular biology
Plasmids encoding the 2 and b1 subunits of the human Na+ /
K+ -ATPase were used. The ‘wild-type’ 2 plasmid contained
the mutations p.Q116R and p.N127D to reduce ouabain sen-
sitivity (Price and Lingrel, 1988). The p.S779N mutation was
introduced by site-directed mutagenesis (QuickChange, Agilent
Technologies) and conﬁrmed by sequencing the whole insert.
ATP1A2 (2) and ATP1B (b1) mRNAs were transcribed using
the mMessage mMachine kit (Ambion).
Oocyte preparation
Xenopus laevis oocytes were obtained following procedures
approved by the UK Animals (Scientiﬁc Procedures) Act
1986. Cells were defolliculated with Collagenase A (Roche)
2mg/ml in oocyte Ringer and stored in modiﬁed Barth’s
Solution supplemented with penicillin (50 U/ml), streptomycin
(50 mg/ml) and amikacin (100 mg/ml) at 14–18C. Oocytes
were injected with a mix of ATP1B (2 ng) and wild-type or
mutant ATP1A2 (10 ng) mRNAs.
Two-electrode voltage clamp
Two-electrode voltage clamp is routinely used to characterize
functional properties of Na+/K+-ATPase pumps (Horisberger
and Kharoubi-Hess, 2002; Li et al., 2006; Poulsen et al.,
2010; Vedovato and Gadsby, 2014; Hilbers et al., 2016).
Data were collected with a GeneClamp 500B ampliﬁer,
Digidata 1200 digitizer and pCLAMP
TM
software (Molecular
Devices) at room temperature. Currents were measured 2–4
days after injection in oocytes preincubated (430min) with a
Na+-loading buffer (Poulsen et al., 2010), unless otherwise men-
tioned. Electrode resistance was 0.2–0.7 M when ﬁlled with
NaCl 3M to allow fast voltage clamp. Currents were elicited
with 200-ms test steps from 160 to +60mV, at 20-mV incre-
ments, from a holding potential of 30mV. Recordings were
sampled at 5 kHz and ﬁltered at 1 kHz. Ouabain 1mM was
included in all recording solutions to block endogenous pumps.
Transient sodium-dependent currents were recorded in 0
[K+ ]o (in mM: NaOH 115, sulphamic acid 110, MgCl2 1,
CaCl2 0.5, BaCl2 5, HEPES 10, pH 7.4) with and without
10mM ouabain, and isolated ofﬂine by subtraction. Scale
was maximized to minimize signal clipping, and 10 traces
were averaged to improve signal-to-noise ratio. The integral
of transient ouabain-sensitive currents at 30mV following
the test voltage steps was plotted against test voltage and
ﬁtted to a Boltzmann function:
f ðVÞ ¼ A1 A2
ð1þ eVVdV Þ
þ A2 ð1Þ
yielding the mid-point potential (V1/2), slope factor (dV) and
top (A1) and bottom (A2) asymptotes. Total charge transfer,
Qtot, represents the span of the Boltzmann ﬁt (A1A2). Rate
constants of Na+ binding/unbinding reactions derived from
single (wild-type) or double (p.S779N) exponential ﬁts to tran-
sient currents at the onset of the pulse. For p.S779N, the fast
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time constant, describing 490% of charge transfer, was ana-
lysed. Boltzmann ﬁts to mean relaxation-voltage curves yielded
the maximal forward and backward rate constants.
Leak currents were measured as the mean ouabain-sensitive
currents in the last 50ms of the test pulse. In some experi-
ments, pH was altered or Na+ was replaced by NMDG+ as
monovalent cation in a 3:1 ratio. In experiments with 145mM
Na+ , 30mM NaOH was added to 0 [K+ ]o solution. Reversal
potential and slope conductance were obtained from linear ﬁts
to the current-voltage data.
Forward pumping activity was measured in various [K+ ]o
concentrations before and after addition of 10mM ouabain.
Records were subtracted ofﬂine. In these experiments, extra-
cellular NaOH was replaced with equimolar KOH.
Concentration-response curves were ﬁt with a Hill equation:
I ðsteady stateÞ ¼ A1þ A2 A1
1þ ½KþoEC50
 h ð2Þ
yielding [K+ ] EC50 values, Hill coefﬁcient (h) and top (A1) and
bottom (A2) asymptotes.
Statistical analysis
Analysis was performed using Clampﬁt 10.7, OriginPro 2016
and GraphPad Prism 4. Fit-derived parameters were compared
with Student’s t-tests or one-way ANOVA. Current-voltage
curves were compared with a two-way ANOVA, where the
dependent variable was ‘current’ and the independent variables
‘voltage’ and ‘gene variant’. Data are presented as
mean  standard error of the mean (SEM) with signiﬁcance
level at P50.05.
Data availability
The authors conﬁrm that the data supporting the ﬁndings of




A 9-year-old Brazilian boy presented with episodes of ﬂac-
cid muscle paralysis. Pregnancy and birth history were un-
remarkable. He experienced absence seizures with ocular
aversion from age 4 months. These were initially resistant
to treatment with status epilepticus occurring at age 1 year
but eventually controlled with a combination of sodium
valproate and levetiracetam. Seizures recurred with increas-
ing age and increased drug doses were required. He had
delayed motor milestones, not walking independently until
2 years 9 months, and speech delay with learning difﬁcul-
ties. At age 2 years he woke with tetraparesis and dyspha-
gia lasting several hours, concomitant with a lower
respiratory tract infection. Symptoms resolved with the in-
fection and no speciﬁc diagnosis was made. He had two
similar episodes at ages 3 and 4 years lasting several days.
Episodes became increasingly frequent, averaging 5–10 per
month. Paralysis attacks were bilateral, not associated with
migraine or headache, occurred usually on waking and
lasted hours to days. Triggers included carbohydrate
meals and viral illness. Creatine kinase ranged from 382
to 1793 IU/l. Serum potassium was low (2.4mM) during
symptoms. Routine electrocardiogram was normal. A
muscle biopsy undertaken shortly after an attack showed
evidence of a non-speciﬁc myopathic process (Fig. 1A).
Brain MRI was normal at 5 months but at 7 years demon-
strated increased prominence of the ventricular system with
bilateral mesial temporal sclerosis. EEG initially demon-
strated epileptic activity although normalized on treatment.
Routine EMG and nerve conduction study were normal but
compound muscle action potential during an attack was
signiﬁcantly reduced compared to post-attack level, con-
ﬁrming peripheral impairment of neuromuscular function.
Symptoms of paralysis improved with potassium supple-
ments but were signiﬁcantly worsened by acetazolamide.
There was no family history of similar symptoms, epi-
lepsy or migraine.
Genetic analysis
No mutations were found in the CACNA1S, SCN4A or
KCNJ2 genes. A novel missense variant, c.G2336A, was
identiﬁed in the ATP1A2 gene, affecting a highly conserved
residue (p.S779) of the 2 subunit of Na+ /K+ -ATPase (Fig.
1B and C) in an ion binding site where Na+ or K+ interact
with Na+ /K+ -ATPases, depending on the conformation
(Fig. 1B and C). This variant is absent in over 120 000
exomes from the Genome Aggregation Database
(gnomAD). The asymptomatic parents did not carry the
variant, suggesting it had arisen de novo.
Functional characterization of
p.S779N Na + /K + -ATPase
Anomalous leak current and sodium affinity
The extracellular Na+ afﬁnity was studied by analysing the
release and rebinding of Na+ ions to the pump in absence
of extracellular K+ . Transient ouabain-sensitive Na+ cur-
rents in response to a series of voltage steps rapidly
declined to zero for the wild-type pump. In contrast, the
p.S779N ATPase carried an abnormal ouabain-sensitive
steady state current following the Na+ transients (Fig. 2A
and B). This leak component was voltage-independent and
reversed at 12.7  1.0mV (n = 27). Its amplitude was
49.2  5.4 nA at 80mV compared to a wild-type leak
of 1.5  0.9 nA (n = 28).
The voltage dependence of transient currents was left-
shifted in mutant pumps by almost 100mV (Fig. 2C;
P5 105) and was less steep than in wild-type pumps
(P5 105), indicating that stronger hyperpolarizations are
needed to reload Na+ binding sites and reﬂecting a reduced
extracellular Na+ afﬁnity of p.S779N. Additionally, the
rate constants of relaxation of transient Na+ currents
showed little voltage-dependence for p.S779N, while for
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Figure 1 Muscle pathology and genetic analysis of the hypoPP patient. (A) Histological examination of a biceps brachii muscle biopsy
performed at age 2 years and 3 months. (i) Haematoxylin and eosin staining showed variation in fibre diameter, increased internal nuclei (black
arrows), a necrotic fibre (white arrow) and subtle endomysial fibrosis (also seen in iii) (ii) Myosin ATPase histochemistry at pH 9.4 indicated type I
fibre predominance (pale stained fibres). (iii) Gomori trichrome staining. (B) Sequence chromatogram demonstrating the heterozygous mutation
c.2336G4A; p.S779N in the proband (above) and sequence alignment of human Na+ /K+ -ATPase alpha subunits. ATP1A2-S779 and analogous
serine residues are underlined. (C) Structural context of S779. Left: An overview of the Na+ /K+ -ATPase structure with the alpha subunit in grey,
the beta subunit in blue and the gamma subunit in red. The two potassium ions are yellow spheres, S779 is in orange stick, and the ion-
coordinating transmembrane helices are light cyan (M4), wheat (M5) and light blue (M6). The boundaries of the membrane are indicated by
horizontal lines. Right: Close-ups of the ion binding sites viewed from the extracellular side, top with two potassium ions (yellow), bottom with
three sodium ions (violet). S779 is close to ion binding sites I and III. The figure was made using PDB structures 2ZXE (potassium bound) and
3WGU (sodium bound).
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the wild-type pump they decreased signiﬁcantly with de-
polarization (Fig. 2A and D). Compared to the wild-type
Na+ /K+ -ATPase, both forward and backward reaction
rates, at depolarized and hyperpolarized voltages respect-
ively, were signiﬁcantly altered in the mutant (P5 0.0001).
Reduced turnover rate and apparent K + affinity
The forward pumping activity of the Na+ /K+ -ATPase
was initially studied in 15mM [K+]o that saturates the
wild-type turnover rate (DiFranco et al., 2015). The out-
ward pump current was reduced in p.S779N compared to
the wild-type ATPase (Fig. 3A and B, P5 0.0001).
Normalization of steady state currents to total Na+
charge movement conﬁrmed a lower turnover rate at volt-
ages positive to 40mV (Fig. 3C, P5 0.001). To test if the
reduced pump currents result from altered K+ afﬁnity, we
studied pump currents in various [K+ ]o. Currents did not
saturate for the p.S779N pump, even with 30mM [K+]o,
Figure 2 Steady state and transient Na+ currents of WT and p.S779N pumps in the absence of extracellular K+ . (A)
Representative raw current traces in absence (left) and presence (middle) of 10mM ouabain and the ouabain-sensitive currents (right) in wild-type
(black) and p.S779N (red) pumps in response to voltage steps from 160 to +60mV, in 20-mV increments. Steady state currents at each voltage
were measured in the last 50ms of the 200ms stimulus, indicated by dotted lines. (B) Average ouabain-sensitive steady state leak currents. Slope
conductance between 140mV and 0mV was 0.75  0.08 nA/mV for the p.S779N pump (n = 27) while it was close to 0 for the wild-type pump
(n = 29). (C) Charge-voltage relationships. Na+ charge transfer was determined from the integral of the first 50ms of the current trace at 30mV
following the steps to test voltages. Individual QV curves were fit by a standard Boltzmann function and normalized to their respective fits. V1/2:
p.S779N 95.4  7.1mV, n = 25; wild-type 2.6  1.7mV, n = 29; slope: p.S779N 66.8  4.8mV, wild-type 28.9  0.7mV, P5 105, unpaired t-test.
(D) Rate constants of transient currents at the onset of the stimulus. Solid line represents a Boltzmann fit and yielded the overall forward/backward
rate constants (p.S779N, 773.9  27.7/542.6  12.7 s1, n = 22 wild-type 102.3  3.6/882.2  32.9 s1, n = 26; P5 0.0001, unpaired t-test).
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while the wild-type pump currents activated and saturated
at lower [K+ ]o (Fig. 3D). The wild-type pump showed a
depolarization-induced increase in K+ afﬁnity while the
EC50 of p.S779N was largely voltage-independent (Fig.
3E) and was higher across all voltages (Fig. 3F, P5 0.001).
Furthermore, in 2–5mM [K+]o the net current in the
mutant pump is inward at hyperpolarized voltages (Fig.
3D), suggesting that the aberrant leak current persists at
physiological [K+ ]o and may interfere with the accurate
estimation of forward pump currents.
Ionic nature of the leak current
The ionic species carrying the inward leak of the p.S779N
pump were investigated in absence of forward pumping
Figure 3 Forward pumping currents of WTand p.S779N a 2 at various extracellular [K + ]o. (A) Example current traces of wild-type
(black) and mutant (red) pumps in response to 200ms steps from 160 to + 40mV, from a holding voltage of 30mV in absence (left) and
presence (middle) of 15mM K+ , and in presence of 15mM K+ and 10mM ouabain (right). K+ -induced pump currents were isolated off-line by
subtraction of currents in the presence of ouabain 10mM. (B) Current-voltage relationship of steady state ouabain-sensitive currents measured in
last 50ms of each step (p.S779N n = 17; wild-type n = 20; P5 0.0001 two-way ANOVA). (C) Current-voltage relationship of ouabain-sensitive
currents normalized to total Na+ charge transfer (Qtot) in absence of K
+ , as a measure of functional protein expression (p.S779N n = 7; wild-type
n = 13; P = 0.001, two-way ANOVA). Qtot was estimated in a subset of cells where lower amplifier gain was used to minimize current saturation
because of capacitive artefacts. Ten traces were averaged to reduce the noise and then used to determine the span of the Boltzman curve (Qtot:
S779N 5.4  0.9 nC, n = 7; wild-type 5.5  0.7 nC, n = 13). (D) Extracellular apparent K+ affinity of the ATPases: current-voltage relationships of
wild-type (i) and mutant pumps (ii) in various [K+ ]o conditions normalized to the outward current at + 20mV in 15mM K
+ (p.S779N n = 5–6;
wild-type n = 3–5). (E) Concentration-response curves obtained from the data in D at three representative voltages. Dotted lines represent fits
to a modified Hill equation (wild-type EC50 at 100, 60, 0mV: 3.5  0.3, 2.2  0.2, 1.3  0.1mM, n = 5; P5 0.0001 repeated measures
ANOVA; p.S779N EC50 at 100, 60, 0mV: 6.9  0.4, 6.9  0.2, 7.5  0.7mM, n = 5; P = 0.7). Curves obtained from separate experiments
were normalized to the top and bottom values of the fit and averaged across oocytes. Hill coefficients were voltage independent and did not
change significantly between pump variants: wild-type 1.54  0.06, S779N 1.56  0.06 (P = 0.3, two-way ANOVA across the voltages). (F) Overall
voltage dependence of apparent [K+ ] affinity (wild-type n = 3–5; p.S779N n = –5, P5 0.001 two-way ANOVA).
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currents in 0 [K+ ]o. Lowering external pH to 6 augmented
the leak current and right-shifted its reversal (Fig. 4A and
B; slope: P = 0.03, Erev: P = 0.01) while increasing pH to
8.2 had the opposite effect but without statistical signiﬁ-
cance (slope: P = 0.15, Erev P = 0.06). Changing pH was of
little consequence for the wild-type pump (Fig. 4A and B).
These results indicate that protons contribute to the leak in
the mutant Na+ /K+ -ATPase. Furthermore, reduction of pH
to 6 in the presence of 15mM [K+]o altered p.S779N
pump currents in a manner consistent with an increased
linear leak component (Fig. 4C), suggesting that the leak
current is present even in high [K+ ]o. This also suggests
that the current measured in presence of [K+ ]o is in fact
the sum of forward pumping current and the leak current
and consequently that the estimation of [K+ ]o dependence
of the outward current is interfered by the presence of the
leak current.
When 75% of the extracellular Na+ was replaced with
NMDG+, the inward leak current of the mutant Na+ /K+ -
ATPase was reduced (Fig. 4D, P = 0.001) along with a
negative shift in reversal potential (P = 0.016). In contrast,
the substitution enhanced steady state currents in the wild-
type pump (Fig. 4D, P = 0.008). When extracellular Na+
was elevated from 115mM to 145mM the slope of the
linear leak current increased and reversal potential shifted
towards positive voltages for p.S779N pumps
(Supplementary Fig. 1, n = 4, P50.05 for both slope con-
ductance and reversal potential). These data point to an
additional contribution of Na+ ions to the leak current
of p.S779N pump.
Finally, as there is controversy in the literature whether
mutation of the serine reduces intracellular sodium afﬁnity
or not (Argu¨ello and Lingrel, 1995; Blostein et al., 1997;
Pedersen et al., 1998), we studied the leak currents of
p.S779N without prior loading of the oocytes. Loading
has been shown to increase the intracellular sodium concen-
tration and thereby stimulate forward pump current of Na+/
K+-ATPases, depending on the sodium afﬁnity of the pump
expressed (Horisberger and Kharoubi-Hess, 2002).
Consistently, we measured small or no potassium-induced
forward pumping for p.S779N and only small currents for
wild-type pumps in unloaded oocytes. The amplitudes of the
charge carried were also markedly reduced for both
p.S779N and wild-type pumps compared to loaded oocytes
(Supplementary Fig. 1B), and no leak currents were detected
for p.S779N in unloaded oocytes (Supplementary Fig. 1C).
Discussion
We have found the p.S779N variant of the Na+ /K+ -
ATPase pump isoform 2 in a patient presenting with
Figure 4 Ionic contributions to the p.S779N ATPase leak current. (A) Representative current traces in 0 [K+ ]o for wild-type (black)
and p.S779N (red) illustrating changes in leak currents with varying [H+ ]o. (B) Steady state current-voltage relationships in different pH con-
ditions normalized to current at + 20mV in pH 7.4 (n = 4 for both). Linear fits to raw leak currents (not shown) in p.S779N indicate an increase in
slope conductance with acidification from 0.54  0.1 to 0.85  0.2 nA/mV (P = 0.03, paired t-test) and a shift in Erev from 12.7  2.5 to
2.2  2.6mV (P = 0.01). For pH 8.2 the slope was 0.43  0.1 (P = 0.15) and Erev = 17.8  2.2mV (P = 0.06). (C) Increase in inward leak
currents in p.S779N pump with acidification in the presence of 15mM [K+]o; comparison with linear leak in Na
+ -only (pH 7.4) conditions (n = 4).
Currents have been normalized to amplitude at + 20 in pH 7.4. (D) Average steady state currents for wild-type (left) or p. S779N (right) pumps in
control conditions (115mM Na+ , 0 K+ ) and when 86mM Na+ is substituted with NMDG+ . Currents have been normalized to control value at
+ 20mV (wild-type n = 6, P = 0.008; p.S779N n = 7, P = 0.001 repeated measures ANOVA). For the mutant pump, Erev shifted from
16.2  1.5mV in Na+ to 48.8  10mV in Na/NMDG+ (n = 7, P = 0.016, Wilcoxon paired t-test).
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hypoPP and CNS symptoms. No mutations were detected
in the known hypoPP genes. The mutation is absent in
exome databases (gnomAD) and in the asymptomatic par-
ents, suggesting it had arisen de novo. This genetic evidence
supports association of the variant with the clinical presen-
tation and the symptoms of the patient are consistent with
the expression of Na+ /K+ -ATPase 2 pump in the skeletal
muscle and the glia. Functional analysis revealed a leak
current in the mutant pump, analogous to gating pore cur-
rents carried by mutant voltage gated sodium and calcium
channels. These currents underlie hypoPP (Cannon, 2015).
The depolarizing inward leak currents in the mutant pump
were measured only at hypokalaemic conditions, consistent
with the low serum potassium measured in the patient
during symptoms. Thus, the functional evidence strongly
supports the association of the variant with periodic par-
alysis in the patient.
Similar to the gating pore leak currents through voltage
gated ion channels associated with hypoPP the inward leak
current can be carried by Na+ ions and protons. In muscle,
proton inﬂux leads to increased intracellular Na+ accumu-
lation through action of the Na+ /H+ -exchanger (Jurkat-
Rott et al., 2009), suggesting that the leak may cause
muscle depolarization by promoting (directly and indir-
ectly) inﬂux of different cation species to muscle ﬁbres.
Wild-type Na+/K+-ATPase 2 pump current density in
muscle is 1mA/cm2 at 90mV in 10mM [K+]o
(DiFranco et al., 2015). Considering that the turnover rate
of the mutant pump is reduced compared to wild-type and
by comparing the relative amplitudes (at 80 and 100mV)
of p.S779N inward leak in low [K+]o and outward current
in high [K+]o, we can estimate that the inward current amp-
litude of the mutant pump in 2mM [K+]o is between one-
third and one-half of the outward wild-type currents at
90mV measured by (DiFranco et al., 2015). Assuming
equivalent allelic expression of p.S779N and wild-type
pumps in heterozygous condition in the muscle, this would
result in a leak current density of 0.17–0.25mA/cm2. This
value is close to the measured gating pore current density in
a mouse model of hypoPP (0.2mA/cm2, Wu et al., 2011).
Despite its small amplitude, this current is sufﬁcient to cause
muscle depolarization particularly in the presence of hypo-
kalaemia, which substantially reduces outward Kir current in
skeletal muscle (Cannon, 2015).
However, it is important to stress that the estimated cur-
rent amplitude is based on heterologous expression in the
absence of any additional pump subunits expressed in skel-
etal muscle, such as FYXD1, in lower extracellular Na+
concentration (Supplementary Fig. 1A) than in muscle
and on recordings at room temperature, although tempera-
ture is not expected to change the proportion of leak and
pump current (Meier et al., 2010). FYXD1 has been shown
to reduce the afﬁnity of the 2 pump for external potas-
sium (Han et al., 2009; Stanley et al., 2015) and would be
anticipated to increase the proportion of the leak current.
These factors suggest that the precise relation of the wild-
type forward pump current and the mutant inward leak
current in muscle may differ from that in our recordings.
Similar expression levels of wild-type and mutant pumps
measured as total transient Na+ -dependent currents in
Xenopus oocytes suggests that the membrane stability of
mutant pumps is not reduced in this system. Altogether
these data suggest that the amplitude of the p.S779N leak
current is in the same range as the hypoPP-associated
gating pore currents and can induce muscle depolarization,
strongly supporting the association of the mutation with
hypoPP.
Many of the 80 mutations in ATP1A2 associated with
CNS phenotypes (Bøttger et al., 2012; Pelzer et al., 2017)
reduce the turnover rate of the 2 Na+ /K+ -pump without
causing skeletal muscle presentations. This suggests that the
leak current, rather than the reduced turnover rate, is
the main pathomechanism of hypoPP in our patient. Two
C-terminal mutant 2 Na+ /K+ -ATPases with only reported
CNS presentations do also conduct leak currents (Poulsen
et al., 2010). However, these leak currents in the absence of
K+ present at voltages negative to 100mV, which means
they are not active at resting membrane voltage. These data
further highlight our proposition that it is the loss-of-func-
tion features of these mutants that underlie the neurological
phenotype in these mutants and in our p.S779N patient.
Similar leak currents have been detected in 1 Na+/K+-
ATPase mutant pumps found in patients with hyperaldoster-
onism (Meyer et al., 2017). In this case the leak current
amplitude at physiological voltages was not sufﬁcient to
result in an inward net current suggesting that the leak cur-
rent does not contribute to the depolarization in these cells.
Rather, the authors suggest loss-of-function mechanism is
common cause for hyperaldosteronism (Meyer et al., 2017).
Although with a single case we cannot completely exclude
chance association of the p.S779N variant with hypoPP in
this patient, the outstanding difference between the func-
tional features of p.S779N and the FHM2-associated muta-
tions—i.e. inward cation leak at voltages near rest—strongly
supports the notion that p.S779N anomalous steady state
currents underlie membrane depolarization and muscle inex-
citability leading to paralysis in patients with hypoPP. Thus,
our data provide important evidence supporting a leak cur-
rent as the major pathomechanism underlying hypoPP and
indicate ATP1A2 as a new hypoPP gene.
Small proton leak currents are an inherent property of
the transport cycle of wild-type Na+ /K+ -ATPases, being
more pronounced in 0 [Na+ ]o and low pH, and effectively
inhibited by forward pumping in saturating [K+ ]o (Wang
and Horisberger, 1995; Horisberger and Kharoubi-Hess,
2002; Vasilyev et al., 2004; Poulsen et al., 2010; Mitchell
et al., 2014; Vedovato and Gadsby, 2014; Hilbers et al.,
2016). We found an abnormally large leak current in
p.S779N, both in low and high [K+ ]o. The leak can out-
balance the pump current at physiological voltages when
[K+ ]o or pH are reduced. Normal leak currents are asso-
ciated with the molecular conformations where extracellu-
lar Na+ is released, the so-called E2P conformation (Li et
al., 2006; Poulsen et al., 2010; Vedovato and Gadsby,
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2014; Stanley et al., 2016; Isaksen et al., 2017). The rela-
tive stabilization of this conformation coupled with a pro-
foundly reduced K+ afﬁnity in the mutant p.S779N pump
likely contribute to the presence of an aberrant leak
current.
Consistent with a key location of the S779 residue on the
highly conserved K+ binding site of the enzyme (Morth et
al., 2007; Fig 1), the p.S779N mutation increases the K+
EC50 of the pump 2–6-fold. In agreement with our results,
when sheep  1 S775, analogous to  2 S779, was mutated
to either alanine, cysteine or tyrosine, the mutants had
markedly reduced afﬁnity for [K+ ]o (Argu¨ello and
Lingrel, 1995; Blostein et al., 1997; Pedersen et al.,
1998). In addition to inducing forward pumping, the effect
of [K+]o likely includes inhibition of the leak current, which
may affect the estimation of K+ afﬁnity of the forward
pumping. Our data indicate that the leak current is present
even at 15mM [K+]o (Fig. 4C). Although we cannot discern
between the two effects of K+ , if both arise from the same
K+ binding step, then the EC50 gives an accurate measure of
reduced K+ afﬁnity of the pump. Inhibition of the leak cur-
rent by elevated [K+]o may explain the beneﬁcial clinical
effect of K+ supplements in the patient. In normokalaemic
conditions the mutant pump does not carry a net inward
current that would lead to depolarization of the cell and
hypoPP. However, an inward leak of H+ during forward
pumping may contribute to the clinical presentation even in
normokalaemia, in particular upon extracellular acidosis.
Reduced net outward current in mutant pump compared
to wild-type pump activity in normokalaemia is qualitatively
similar to loss of function mutation associated with FHM
and is likely to contribute to the CNS presentation.
Moreover, the left-shifted voltage dependence of transient
Na+ -dependent currents indicate a reduced [Na+ ]o afﬁnity
of p.S779N 2. Different mutations of 1 S775 have been
shown to reduce [Na+ ]i afﬁnity 8–14-fold (Pedersen et al.,
1998), not affect it (Argu¨ello and Lingrel, 1995) or reduce
it slightly by 1.5-fold (Blostein et al., 1997). Therefore, we
tested p.S779N in oocytes without initially raising the
[Na+ ]i, and detected no leak currents under these condi-
tions. The low intracellular sodium level also restricted for-
ward currents from both the mutant and wild-type pumps,
suggesting that they become halted in the catalytic cycle at
E1. Reduced [Na+ ]i afﬁnity of p.S779N may therefore limit
it from entering the E2P state(s) that are generally sug-
gested to be associated with conducting inward leak cur-
rents (Nyblom et al., 2013; Stanley et al., 2016).
Consequently, it is feasible that the leak currents are only
physiologically relevant at elevated intracellular sodium
concentrations, for example [Na+ ]i can increase 3-fold
upon electrical stimulation (Fong et al., 1986). In the pa-
tient, the effect would be a negative loop where high intra-
cellular sodium levels would be even further increased by
the mutant pump, counteracting the actions of the pump
from the wild-type allele.
The CNS symptoms in the proband are similar to the epi-
leptic and cognitive phenotypes observed in some FHM2 and
alternating hemiplegia of childhood patients carrying loss-of-
function mutations in 2. This suggests that the reduced Na+
and K+ turnover of the p.S779N pump contributes to CNS
dysfunction. The 2 Na+/K+-ATPase specializes in fast K+
clearance from the diffusion-restricted spaces of the T-tubules
(DiFranco et al., 2015) and synapses (Larsen et al., 2014),
where K+ concentrations rise above 10mM during periods
of activity. Reduced astrocytic K+ and Na+ pumping may
therefore lead to synaptic K+ accumulation and disruption of
Na+-dependent secondary transport processes, such as glutam-
ate clearance (Illarionova et al., 2014) and Ca2+ signalling
(Golovina et al., 2003), thereby contributing to the CNS
phenotype. The role of the p.S779N leak current in astrocyte
function remains to be investigated.
Clinical implications
Our data implicate ATP1A2 as a new hypoPP gene and
leak currents as a common pathomechanism of hypoPP.
To our knowledge this is the ﬁrst report of a mutation in
a non-channel gene resulting in a leak current associated
with hypoPP. Since at least 10% of hypoPP cases are gen-
etically undeﬁned, we propose that genetic screening, in
combination with functional characterization, may link fur-
ther cases with mutations in ATP1A2 and potentially other
genes encoding transmembrane proteins expressed at simi-
lar levels in skeletal muscle.
No cardiac presentations have been reported for the
ATP1A2 variants associated with CNS and skeletal muscle
symptoms despite expression of 2 in the heart. In this
tissue, however, this isoform accounts for 520% of the
total Na+/K+ ATPase contents (as opposed to 85% in skel-
etal muscle) (Orlowski and Lingrel, 1988; Berry et al., 2007;
Radzyukevich et al., 2013). Hence, the detrimental effects of
the leak current and loss-of-function properties of p.S779N in
the heart may be negligible. Lack of cardiac manifestations
may also arise due to differential localization or regulation of
the pump in cardiac muscle (Juhaszova and Blaustein, 1997),
or to tissue speciﬁc compensatory mechanisms for the effects of
ATP1A2 mutations such as different ion channel expression
pattern. Notwithstanding these facts, it is reasonable to suggest
that patients carrying ATP1A2 variants may be monitored for
cardiac dysfunction, in addition to skeletal muscle dysfunction.
Acetazolamide is a common treatment for hypoPP
(Matthews et al., 2011). It causes metabolic acidosis predicted
to increase the leak current through the p.S779N pump, con-
sistent with acetazolamide worsening muscle symptoms in our
patient. This implies that acetazolamide should be avoided in
cases associated with ATP1A2 mutations that result in H+-
carried leak currents. Instead, our ﬁndings suggest that increas-
ing [K+]o with K
+ supplements or K+-sparing diuretics will
boost pump activity, promoting net outward currents through
the p.S779N pump and compensating the inward leak. This
may reduce the incidence of episodes of paralysis.
In summary, we present a child with hypoPP carrying a
novel mutation in ATP1A2. CNS symptoms are also pre-
sent, distinct from other hypoPP cases. Electrophysiological
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studies of the p.S779N mutant pump reveal an anomalous
inward leak current and altered turnover rates, providing a
mechanistic explanation for the periodic paralysis and CNS
symptoms, respectively. Our results indicate that ATP1A2
is a new hypoPP gene.
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